A retrospective longitudinal cohort study examined how age modifies the association between Down syndrome (DS) and ten common disease conditions. The analysis used clinical encounter data from a Midwest healthcare system spanning January 2005 through May 2025 to compare disease incidence between individuals with DS and a matched typically developing (TD) control cohort.
The study population comprised 4,912 individuals with DS and 37,924 TD controls. Total person-years (PYs) of observation were 25,896 for the DS cohort and 149,078 for controls. The median age of the DS cohort was 24 years; 48% were female. Researchers treated DS status as the exposure and assessed incidence of ten predefined conditions.
Analyses estimated incidence rate ratio (IRR) trajectories across age using generalized additive mixed models. Wald tests were used to formally assess whether age modified the association between DS and each condition.
Ten outcomes were evaluated: acute sinusitis, anxiety, asthma, depression, gastroesophageal reflux disease (GERD), nervous system disorders, respiratory failure, thyroid gland disorders, vasomotor/allergic rhinitis, and vitamin D deficiency. Incidence was reported as events per 1,000 person-years and as age-specific IRRs comparing individuals with DS to TD controls.
The authors report evidence of age-related effect modification for 6 of the 10 conditions studied. For anxiety, the relative incidence among individuals with DS was substantially lower in early childhood compared with TD peers (at age 5 the IRR was 0.23, 95% CI 0.19–0.29). Over the life course the relative risk in the DS cohort increased and approached equivalence with the TD cohort by approximately age 65.
A similar age-dependent pattern was described for depression, in which relative incidence among people with DS rose with age and moved closer to levels observed in TD controls in older adulthood. The abstract provides the general trajectory but does not report detailed age-specific IRR values across all ages for depression beyond this summary.
Overall the association between DS and gastroesophageal disease was largely null. However, the study identified a distinct window in early childhood (approximately ages 1–8) during which incidence among individuals with DS was elevated relative to TD controls. During that age interval GERD incidence in DS was about 5–7 cases per 1,000 PYs versus 2–3 cases per 1,000 PYs in controls.
The incidence of respiratory failure did not differ significantly between cohorts through much of adult life. Between roughly ages 53 and 70, however, the incidence among individuals with DS rose sharply to an estimated 13–30 cases per 1,000 PYs, while incidence in TD counterparts remained approximately 8–9 cases per 1,000 PYs. This pattern produced a late-life relative increase in risk for respiratory failure in the DS cohort.
The study identified fluctuating relative risk for vitamin D deficiency across age, with a pronounced peak around age 20 when the IRR was reported as 2.34 (95% CI 2.02–2.72) for individuals with DS relative to TD controls. The abstract does not provide full age-stratified incidence values beyond this peak description.
The remaining evaluated conditions included acute sinusitis, asthma, nervous system disorders, thyroid gland disorders, and vasomotor/allergic rhinitis. The abstract indicates that age-related modification was present for a total of six conditions but details describing the sixth condition with age modification and full age-specific trajectories for several outcomes were not reported in the abstract. For conditions not discussed in detail, the abstract either found no strong age-modified association or did not provide age-specific effect descriptions.
The authors conclude these age-varying associations demonstrate that disease risk among people with DS can differ from TD populations in an age-dependent manner. Because current age-based screening and prevention guidelines are typically developed in populations without DS, the findings underscore the potential need for population-specific and age-informed care strategies to identify windows of increased risk and optimize preventive care.
The study is retrospective and based on electronic clinical encounter data from a single Midwest healthcare system. Data produced are not publicly available owing to institutional protected health information restrictions; analytic code is available from the authors on request. The protocol was approved by the Advocate Health Institutional Review Board (IRB #00132715) with a waiver of informed consent due to the retrospective design. The authors declared no competing interests.
Note: The abstract reports age effect modification in 6 of 10 conditions and describes trajectories for anxiety, depression, GERD, respiratory failure, and vitamin D deficiency. Specific age-pattern details for the sixth condition with modification and full age-stratified incidence tables were not reported in the abstract and would require review of the full manuscript or supplementary materials for complete values.